Prenetics Global PRE
NASDAQ PRE
$26.29 +0.51 (+1.98%)
As of: Aug 27, 2026 · 3:59 PM EDT

Prenetics Global (PRE) Non Operating Investment Income (2021 - 2025)

Prenetics Global (PRE) posted quarterly Non Operating Investment Income of $2.0 million for Q4 2025, up 800.03% quarter-over-quarter from -$292132.0 in Q4 2021.

Prenetics Global (PRE) Non Operating Investment Income (2021 - 2025) Analysis & Trends

Prenetics Global (PRE) has reported Non Operating Investment Income for 2 consecutive years, with $2.0 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Non Operating Investment Income changed N/A year-over-year to $2.0 million; the TTM figure through Dec 2025 stood at -$20.0 million (changed N/A YoY), while the FY2025 annual figure was $2.0 million, changed N/A from the prior year.
  • Non Operating Investment Income advanced to $2.0 million in Q4 2025 per PRE's latest filing, from -$292132.0 in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $2.0 million in Q4 2025 and bottomed at -$21.8 million in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -
10 Prenetics Global 368.73 Mn 309.68 Mn 30.20 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.05 Mn
Dec 31, 2025 -2.05 Mn
Dec 31, 2021 -292,132.00
Dec 31, 2021 -292,132.00